JPM Thematics - Genetic Therapies C2 Fonds
84,68
CHF
+1,13
CHF
+1,35
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Sarepta Therapeutics Inc | US8036071004 | 3,38% |
| Novartis AG Registered Shares | CH0012005267 | 3,35% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,05% |
| Krystal Biotech Inc | US5011471027 | 2,97% |
| Vericel Corp | US92346J1088 | 2,94% |
| Ionis Pharmaceuticals Inc | US4622221004 | 2,88% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 2,88% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 2,79% |
| Gilead Sciences Inc | US3755581036 | 2,75% |
| Iovance Biotherapeutics Inc | US4622601007 | 2,72% |
| Sonstige | 70,30% |